DSSTox_CID_2934

Synopsis

Synopsis

APIs // Active Pharmaceutical Ingredients

16 Suppliers, 11 USDMF, 7 CEP/COS, 6 JDMF, 4 EU WC, 5 Listed Suppliers

DOSSIERs // Finished Dosage Forms

95 Dossiers, 31 FDA Orange Book, 25 Europe, 13 Canada, 5 Australia, 10 South Africa, 11 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 0.0625MG, TABLET;ORAL - 0.125MG, TABLET;ORAL - 0.1875MG, TABLET;ORAL - 0.25MG, ELIXIR;ORAL - 0.05MG/ML, INJECTABLE;INJECTION - 0.1MG/ML, INJECTABLE;INJECTION - 0.25MG/ML

RELATED EXCIPIENT SUPPLIERS

Suppliers, 28 Kerry, 27 Roquette, 16 Gangwal Chemicals, 14 Microlex e.U, 10 Sigachi Industries, 10 SPI Pharma, 8 Vasa Pharmachem, 6 DFE Pharma, 6 BASF, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Rochem International Inc, 2 Shijiazhuang Huaxu Pharmaceutical, 1 Finar, 1 Ideal Cures Pvt Ltd, 1 Seppic, 1 Capsugel, 1 Pfanstiehl, Inc, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

76 Fillers, Diluents & Binders, 36 Direct Compression, 22 Disintegrants & Superdisintegrants, 20 Granulation, 14 Lubricants & Glidants, 12 Chewable & Orodispersible Aids, 11 Taste Masking, 11 Thickeners and Stabilizers, 10 Film Formers & Plasticizers, 9 Co-Processed Excipients, 8 Coating Systems & Additives, 7 Controlled & Modified Release, 5 Parenteral, 3 Topical, 2 API Stability Enhancers, 1 Solubilizers, 1 Soft Gelatin, 1 Rheology Modifiers, 1 Emulsifying Agents